NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE)

Prospective study will establish a comprehensive international registry specifically for patients who have undergone surgery for primary breast cancer without SLNB. The main objective of this registry is to gather detailed, real-world data on the outcomes of this particular treatment approach, providing insights into the clinical efficacy and quality of life of patients when SLNB is omitted.

NCT Number	NCT07370571
Lead Sponsor	Clinica Universidad de Navarra, Universidad de Navarra
Conditions	Breast Cancer
Enrollment	827 participants
Start Date	2026-03-01
Primary Completion	2027-03-30 (estimated)
Study Completion	2032-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-27